CCCC · Company research
C4 Therapeutics, Inc. (CCCC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year? | MacroGenics (MGNX) and C4 Therapeutics (CCCC) are outperforming the broader Medical sector year-to-date. MGNX has returned 120.5% compared to a -0.4% average for Medical stocks, with analyst consensus estimates for full-year earnings up 50.6% over the past three months. CCCC has returned 49.2% with a 1.7% increase in consensus EPS estimates. Both stocks hold Zacks Rank #2 (Buy) ratings. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 1 | 1 |
| Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. - Stock Titan | Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) - Stock Titan | Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. - Stock Titan | In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance | Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes - Stock Titan | C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| C4 Therapeutics Q2 Revenue Rises to $6.6 Million | CCCC Stock News - Quiver Quantitative | C4 Therapeutics Q2 Revenue Rises to $6.6 Million | CCCC Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 7, 2026 | neutral | 0 | 0.6 |
| $CCCC stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $CCCC stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 1, 2026 | neutral | 0 | 0.6 |
| CCCC Stock Climbs As C4 Therapeutics Posts Strong Phase 1 Myeloma Data - StocksToTrade | CCCC Stock Climbs As C4 Therapeutics Posts Strong Phase 1 Myeloma Data StocksToTrade | View source ↗ | StocksToTrade | Jun 30, 2026 | neutral | 0 | 0.6 |
| $CCCC stock is up 12% today. Here's what we see in our data. - Quiver Quantitative | $CCCC stock is up 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | May 27, 2026 | neutral | 0 | 0.6 |
| CCCC Stock Reverses Pre-Market Gains After Roche Tie-Up To Develop Cancer Treatments - Retail Sees Strong Upside - Stocktwits | CCCC Stock Reverses Pre-Market Gains After Roche Tie-Up To Develop Cancer Treatments - Retail Sees Strong Upside Stocktwits | View source ↗ | Stocktwits | Apr 9, 2026 | neutral | 0 | 0.6 |
| Analysts See Significant Upside in C4 Therapeutics (CCCC) Stock - Yahoo Finance | Analysts See Significant Upside in C4 Therapeutics (CCCC) Stock Yahoo Finance | View source ↗ | Yahoo Finance | Mar 24, 2026 | neutral | 0 | 0.6 |
| $CCCC stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $CCCC stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.